首页> 外文OA文献 >Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial

【2h】

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial

机译：添加或不使用唑来膦酸治疗激素依赖性前列腺癌的塞来昔布：自适应，多臂，多阶段，平台，随机对照试验的长期生存结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
Wagstaff John;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种 eng
中图分类

相似文献

外文文献
专利

1. Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naive Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial [J] . Mason Malcolm D., Clarke Noel W., James Nicholas D., Journal of Clinical Oncology . 2017,第14期

机译：添加细胞和没有唑酮酸的激素 - 野前列腺癌：来自适应性，多神，多级，平台，随机对照试验的长期存活结果
2. Addition of Docetaxel, Zoledronic Acid, or Both to First-line Long-term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial [J] . Sternberg Cora N. European urology . 2016,第6期

机译：将多西他赛，唑来膦酸或两者同时用于前列腺癌一线长期激素治疗（STAMPEDE）：适应性，多臂，多阶段，平台随机对照试验的生存结果
3. Re: Addition of Docetaxel, Zoledronic Acid, or Both to First-Line Long-Term Hormone Therapy in Prostate Cancer (STAMPEDE): Survival Results from an Adaptive, Multiarm, Multistage, Platform Randomised Controlled Trial [J] . Taneja Samir S. The Journal of Urology . 2016,第4期

机译：Re：加入多西紫杉醇，唑醇，或两种前列腺癌中的一线长期激素治疗：自适应，多神，多级，平台随机对照试验的生存结果
4. Radium-223 Dichloride Monotherapy and Combination Therapy with Zoledronic Acid or Doxorubicin Improve Survival in a Mouse Model of Breast Cancer Bone Metastasis [C] . Jukka Rissanen, Mari Suominen, Rami K?k?nen, Molecular Medicine TRI-CON. . 2014

机译：镭-223二氯化物单疗法和组合治疗唑醇或多柔比星改善了乳腺癌骨转移的小鼠模型中的存活
5. Design of Adaptive Multiarm Multistage Clinical Trials [D] . Ghosh, Pranab. 2018

机译：自适应多臂多阶段临床试验的设计
6. Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive Multiarm Multistage Platform Randomized Controlled Trial [O] . Malcolm D. Mason, Noel W. Clarke, Nicholas D. James, -1

机译：含或不含唑来膦酸的塞来昔布用于未经激素治疗的前列腺癌：自适应多臂多阶段平台随机对照试验的长期生存结果
7. Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial [O] . Mason Malcolm D., Clarke Noel W., James Nicholas D., 2017

机译：含或不含唑来膦酸的塞来昔布用于未经激素治疗的前列腺癌：自适应，多臂，多阶段，平台，随机对照试验的长期生存结果

Adding Celecoxib With or Without Zoledronic Acid for Hormone-Naïve Prostate Cancer: Long-Term Survival Results From an Adaptive, Multiarm, Multistage, Platform, Randomized Controlled Trial

著录项

相似文献

相关主题

期刊订阅